Procurement of storage and stability services to maintain BARDA’s supply of Live Attenuated Influenza Virus Master and Working Seed Lots

Biomedical Advanced Research and Development Authority (BARDA), within the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS) awarded a Firm Fixed Price sole source purchase order with Medimmune, LLC, located at One Medimmune Way, Gaithersburg, Maryland 20878-4028 for the procurement of storage and stability services to maintain BARDA’s supply of Live Attenuated Influenza Virus Master and Working Seed Lots.

The government awarded a sole source purchase order to MedImmune, LLC., per FAR 6.302‑1, as no other source would satisfy agency requirements. MedImmune was awarded an indefinite-delivery, indefinite-quantity (ID/IQ) contract for the acquisition of Medical Countermeasures (MCMs) for Pandemic Influenza in 2016. Under that contract, task orders were issued to produce cGMP Influenza Vaccine Master and Working Seed Lots, including storage and stability testing of the seed lots. Since the IDIQ award, MedImmune has been performing storage and stability testing of the Live Attenuated Master and Working Seed Lots. The seed lots are used for the production of clinical trial material or commercial-scale drug substances for pandemic preparedness. Storage and stability testing of the seed lots is required to ensure they remain within the specification of this requirement.